These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 10980166)

  • 41. Inhibition of Candida albicans biofilm formation on denture material.
    Redding S; Bhatt B; Rawls HR; Siegel G; Scott K; Lopez-Ribot J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):669-72. PubMed ID: 19426921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Miltefosine inhibits Candida albicans and non-albicans Candida spp. biofilms and impairs the dispersion of infectious cells.
    Vila T; Ishida K; Seabra SH; Rozental S
    Int J Antimicrob Agents; 2016 Nov; 48(5):512-520. PubMed ID: 27667564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H; Porter SR; McCullough M; Pratten J
    J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.
    Maiolo EM; Oliva A; Furustrand Tafin U; Perrotet N; Borens O; Trampuz A
    J Infect; 2016 Mar; 72(3):386-92. PubMed ID: 26723911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors.
    Vila T; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the antifungal effect of EDTA, a metal chelator agent, on Candida albicans biofilm.
    Casalinuovo IA; Sorge R; Bonelli G; Di Francesco P
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1413-1420. PubMed ID: 28387883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency.
    Tabbene O; Azaiez S; Di Grazia A; Karkouch I; Ben Slimene I; Elkahoui S; Alfeddy MN; Casciaro B; Luca V; Limam F; Mangoni ML
    J Appl Microbiol; 2016 Feb; 120(2):289-300. PubMed ID: 26669801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms.
    Bink A; Kucharíková S; Neirinck B; Vleugels J; Van Dijck P; Cammue BP; Thevissen K
    J Infect Dis; 2012 Dec; 206(11):1790-7. PubMed ID: 22984120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biofilms of Candida albicans and their associated resistance to antifungal agents.
    Ramage G; Wickes BL; Lopez-Ribot JL
    Am Clin Lab; 2001 Aug; 20(7):42-4. PubMed ID: 11570274
    [No Abstract]   [Full Text] [Related]  

  • 51. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis.
    Auler ME; Morreira D; Rodrigues FF; Abr Ao MS; Margarido PF; Matsumoto FE; Silva EG; Silva BC; Schneider RP; Paula CR
    Med Mycol; 2010 Feb; 48(1):211-6. PubMed ID: 20055746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utilising polyphenols for the clinical management of Candida albicans biofilms.
    Shahzad M; Sherry L; Rajendran R; Edwards CA; Combet E; Ramage G
    Int J Antimicrob Agents; 2014 Sep; 44(3):269-73. PubMed ID: 25104135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms.
    Mitchell KF; Taff HT; Cuevas MA; Reinicke EL; Sanchez H; Andes DR
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1918-20. PubMed ID: 23318790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antifungal susceptibility of Candida albicans biofilms on titanium discs with different surface roughness.
    Tsang CS; Ng H; McMillan AS
    Clin Oral Investig; 2007 Dec; 11(4):361-8. PubMed ID: 17522902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
    Haque F; Alfatah M; Ganesan K; Bhattacharyya MS
    Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production and Isolation of the Candida Species Biofilm Extracellular Matrix.
    Heredia MY; Andes D
    Methods Mol Biol; 2022; 2542():257-268. PubMed ID: 36008671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel entries in a fungal biofilm matrix encyclopedia.
    Zarnowski R; Westler WM; Lacmbouh GA; Marita JM; Bothe JR; Bernhardt J; Lounes-Hadj Sahraoui A; Fontaine J; Sanchez H; Hatfield RD; Ntambi JM; Nett JE; Mitchell AP; Andes DR
    mBio; 2014 Aug; 5(4):e01333-14. PubMed ID: 25096878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of biofilms in antimicrobial resistance.
    Donlan RM
    ASAIO J; 2000; 46(6):S47-52. PubMed ID: 11110294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of the extracellular matrix in Candida biofilm antifungal resistance.
    Massey J; Zarnowski R; Andes D
    FEMS Microbiol Rev; 2023 Nov; 47(6):. PubMed ID: 37816666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.